| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Endocrinology, Vol 8, 1764-1773, Copyright © 1994 by Endocrine Society
ARTICLES |
KL Burnstein, CM Jewell, M Sar and JA Cidlowski
Department of Physiology, Lineberger Comprehensive Cancer Research Center, University of North Carolina, Chapel Hill 27599-7545.
Glucocorticoid receptors (GR) are ligand-dependent transcription factors that play a critical role in the endocrine control of cell growth, differentiation, and death. These steroid receptors are widely recognized to undergo down-regulation after exposure to ligand in cell cultures and animals, including humans. This reduction in cellular receptor levels leads to insensitivity to subsequent hormone administration. The mechanisms controlling homologous down-regulation of the GR are, however, poorly understood. We have previously shown (1) that a transfected human GR (hGR) complementary DNA (cDNA) contains sequences that are sufficient to recapitulate the down-regulation of both hGR messenger RNA (mRNA) and protein seen in vivo. We have now evaluated potential mechanisms involved in the hormonal regulation of the hGR mRNA and, further, have identified an intragenic domain of the hGR cDNA that contains the down-regulatory signal. Glucocorticoid treatment of COS-1 cells expressing a transfected hGR cDNA resulted in down-regulation of the hGR mRNA in the presence of cycloheximide or actinomycin-D, suggesting that a glucocorticoid-inducible protein was not essential for down-regulation. We show that prolonged receptor occupation by ligand leads to increased GR mRNA turnover, and furthermore, that either the agonist dexamethasone or the antagonist RU486 decreased transcription of the hGR cDNA. To resolve which receptor cDNA sequences are critical in down-regulation, a cotransfection strategy was employed in which a series of hGR cDNA deletion mutants was transfected in conjunction with the full-length hGR cDNA. The effects of glucocorticoid on the regulation of receptor mRNAs encoded by the mutant receptor cDNAs were examined. Deletions within the 5' half of the receptor cDNA produced transcripts that were susceptible to glucocorticoid-mediated down-regulation, whereas deletion of sequences located in the 3'-end of the receptor-coding sequence (corresponding to amino acids 550-697) resulted in receptor transcripts that were only minimally down-regulated by glucocorticoid. Together these studies indicate that multiple mechanisms control GR mRNA abundance, and an intragenic element within the ligand-binding domain is critical for this down-regulation.
This article has been cited by other articles:
![]() |
S. R. De Antonio, L. T. S. Saber, R. S. Chriguer, and M. de Castro Glucocorticoid resistance in dialysis patients may impair the kidney allograft outcome Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1422 - 1428. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hagendorf, J. W. Koper, F. H. de Jong, A. O. Brinkmann, S. W. J. Lamberts, and R. A. Feelders Expression of the Human Glucocorticoid Receptor Splice Variants {alpha}, {beta}, and P in Peripheral Blood Mononuclear Leukocytes in Healthy Controls and in Patients with Hyper- and Hypocortisolism J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6237 - 6243. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. S. Kim, S.-W. Jang, H. J. Sung, H. J. Lee, I. S. Kim, D. S. Na, and J. Ko Role of 14-3-3{eta} as a Positive Regulator of the Glucocorticoid Receptor Transcriptional Activation Endocrinology, July 1, 2005; 146(7): 3133 - 3140. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang and D. B. DeFranco Alternative Effects of the Ubiquitin-Proteasome Pathway on Glucocorticoid Receptor Down-Regulation and Transactivation Are Mediated by CHIP, an E3 Ligase Mol. Endocrinol., June 1, 2005; 19(6): 1474 - 1482. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Bachmann, R. Gorman, K. L. MacKenzie, L. Lutze-Mann, and R. B. Lock Dexamethasone resistance in B-cell precursor childhood acute lymphoblastic leukemia occurs downstream of ligand-induced nuclear translocation of the glucocorticoid receptor Blood, March 15, 2005; 105(6): 2519 - 2526. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I Freeman, H. L Munn, V. Lyons, A. Dammermann, J. R Seckl, and K. E Chapman Glucocorticoid down-regulation of rat glucocorticoid receptor does not involve differential promoter regulation J. Endocrinol., November 1, 2004; 183(2): 365 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Szatmary, M. J. Garabedian, and J. Vilcek Inhibition of Glucocorticoid Receptor-mediated Transcriptional Activation by p38 Mitogen-activated Protein (MAP) Kinase J. Biol. Chem., October 15, 2004; 279(42): 43708 - 43715. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Purton, J. A. Monk, D. R. Liddicoat, K. Kyparissoudis, S. Sakkal, S. J. Richardson, D. I. Godfrey, and T. J. Cole Expression of the Glucocorticoid Receptor from the 1A Promoter Correlates with T Lymphocyte Sensitivity to Glucocorticoid-Induced Cell Death J. Immunol., September 15, 2004; 173(6): 3816 - 3824. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. W. Chan, T. T. Lao, P. C. Ho, E. O. P. Sung, and A. N. Y. Cheung The Effect of Mifepristone on the Expression of Steroid Hormone Receptors in Human Decidua and Placenta: A Randomized Placebo-Controlled Double-Blind Study J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5846 - 5850. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. M. Schaaf and J. A. Cidlowski Molecular Determinants of Glucocorticoid Receptor Mobility in Living Cells: the Importance of Ligand Affinity Mol. Cell. Biol., March 15, 2003; 23(6): 1922 - 1934. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, J. L. Pongrac, and D. B. DeFranco Glucocorticoid Receptors in Hippocampal Neurons that Do Not Engage Proteasomes Escape from Hormone-Dependent Down-Regulation but Maintain Transactivation Activity Mol. Endocrinol., September 1, 2002; 16(9): 1987 - 1998. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wang, J. Frederick, and M. J. Garabedian Deciphering the Phosphorylation "Code" of the Glucocorticoid Receptor in Vivo J. Biol. Chem., July 12, 2002; 277(29): 26573 - 26580. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. CROCHEMORE, T. M. MICHAELIDIS, D. FISCHER, J.-P. LOEFFLER, and O. F. X. ALMEIDA Enhancement of p53 activity and inhibition of neural cell proliferation by glucocorticoid receptor activation FASEB J, June 1, 2002; 16(8): 761 - 770. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Wallace and J. A. Cidlowski Proteasome-mediated Glucocorticoid Receptor Degradation Restricts Transcriptional Signaling by Glucocorticoids J. Biol. Chem., November 9, 2001; 276(46): 42714 - 42721. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Breslin, C.-D. Geng, and W. V. Vedeckis Multiple Promoters Exist in the Human GR Gene, One of Which Is Activated by Glucocorticoids Mol. Endocrinol., August 1, 2001; 15(8): 1381 - 1395. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Webster, R. H. Oakley, C. M. Jewell, and J. A. Cidlowski Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: A mechanism for the generation of glucocorticoid resistance PNAS, May 24, 2001; (2001) 121455098. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Whorwood, S. J. Donovan, P. J. Wood, and D. I. W. Phillips Regulation of Glucocorticoid Receptor {{alpha}} and {beta} Isoforms and Type I 11{beta}-Hydroxysteroid Dehydrogenase Expression in Human Skeletal Muscle Cells: A Key Role in the Pathogenesis of Insulin Resistance? J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2296 - 2308. [Abstract] [Full Text] |
||||
![]() |
L. Pujols, J. Mullol, M. Pérez, J. Roca-Ferrer, M. Juan, A. Xaubet, J. A. Cidlowski, and C. Picado Expression of the Human Glucocorticoid Receptor {alpha} and {beta} Isoforms in Human Respiratory Epithelial Cells and Their Regulation by Dexamethasone Am. J. Respir. Cell Mol. Biol., January 1, 2001; 24(1): 49 - 57. [Abstract] [Full Text] |
||||
![]() |
C. L. Mann and J. A. Cidlowski Glucocorticoids Regulate Plasma Membrane Potential During Rat Thymocyte Apoptosis in Vivo and in Vitro Endocrinology, January 1, 2001; 142(1): 421 - 429. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Rogatsky, A. B. Hittelman, D. Pearce, and M. J. Garabedian Distinct Glucocorticoid Receptor Transcriptional Regulatory Surfaces Mediate the Cytotoxic and Cytostatic Effects of Glucocorticoids Mol. Cell. Biol., July 1, 1999; 19(7): 5036 - 5049. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. A. Savory, B. Hsu, I. R. Laquian, W. Giffin, T. Reich, R. J. G. Hache, and Y. A. Lefebvre Discrimination between NL1- and NL2-Mediated Nuclear Localization of the Glucocorticoid Receptor Mol. Cell. Biol., February 1, 1999; 19(2): 1025 - 1037. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kritzik, B. Savage, D. J. Nugent, S. Santoso, Z. M. Ruggeri, and T. J. Kunicki Nucleotide Polymorphisms in the alpha 2 Gene Define Multiple Alleles That Are Associated With Differences in Platelet alpha 2beta 1 Density Blood, October 1, 1998; 92(7): 2382 - 2388. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. I. McKay and J. A. Cidlowski Cross-Talk between Nuclear Factor-{kappa}B and the Steroid Hormone Receptors: Mechanisms of Mutual Antagonism Mol. Endocrinol., January 1, 1998; 12(1): 45 - 56. [Abstract] [Full Text] |
||||
![]() |
S. Boronat, H. Richard-Foy, and B. Pina Specific Deactivation of the Mouse Mammary Tumor Virus Long Terminal Repeat Promoter upon Continuous Hormone Treatment J. Biol. Chem., August 29, 1997; 272(35): 21803 - 21810. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Santagati, E. Gianazza, P. Agrati, E. Vegeto, C. Patrone, G. Pollio, and A. Maggi Oligonucleotide Squelching Reveals the Mechanism of Estrogen Receptor Autologous Down-Regulation Mol. Endocrinol., June 1, 1997; 11(7): 938 - 949. [Abstract] [Full Text] |
||||
![]() |
J. C. Webster, C. M. Jewell, J. E. Bodwell, A. Munck, M. Sar, and J. A. Cidlowski Mouse Glucocorticoid Receptor Phosphorylation Status Influences Multiple Functions of the Receptor Protein J. Biol. Chem., April 4, 1997; 272(14): 9287 - 9293. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. M. Dahia, J. Honegger, M. Reincke, R. A. Jacobs, A. Mirtella, R. Fahlbusch, G. M. Besser, S. L. Chew, and A. B. Grossman Expression of Glucocorticoid Receptor Gene Isoforms in Corticotropin-Secreting Tumors J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1088 - 1093. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. B. E. Oldenburg, R. B. Evans-Storms, and J. A. Cidlowski In Vivo Resistance to Glucocorticoid-Induced Apoptosis in Rat Thymocytes with Normal Steroid Receptor Function in Vitro Endocrinology, February 1, 1997; 138(2): 810 - 818. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Oakley, M. Sar, and J. A. Cidlowski The Human Glucocorticoid Receptor beta Isoform J. Biol. Chem., April 19, 1996; 271(16): 9550 - 9559. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Webster, R. H. Oakley, C. M. Jewell, and J. A. Cidlowski Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: A mechanism for the generation of glucocorticoid resistance PNAS, June 5, 2001; 98(12): 6865 - 6870. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |